Format

Send to

Choose Destination
Joint Bone Spine. 2017 Jan;84(1):1-4. doi: 10.1016/j.jbspin.2016.09.012. Epub 2016 Nov 4.

CRISPR-Cas9: A revolution in genome editing in rheumatic diseases.

Author information

1
Inserm, U1183, IRMB, université de Montpellier, clinical department for osteoarticular diseases, CHRU de Montpellier, 80, rue Augustin-Fliche, 34295 Montpellier, France.
2
Museum national d'histoire naturelle, structure et instabilité des génomes, Inserm U 1154 - CNRS UMR 7196, 43, rue Cuvier, 75231 Paris, France.
3
Inserm, U1183, IRMB, université de Montpellier, clinical department for osteoarticular diseases, CHRU de Montpellier, 80, rue Augustin-Fliche, 34295 Montpellier, France. Electronic address: florence.apparailly@inserm.fr.

KEYWORDS:

CRISPR-Cas; Genome editing; Rheumatism

PMID:
27825565
DOI:
10.1016/j.jbspin.2016.09.012
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center